+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Simultaneous analysis of dextran-methylprednisolone succinate, methylprednisolone succinate, and methylprednisolone by size-exclusion chromatography



Simultaneous analysis of dextran-methylprednisolone succinate, methylprednisolone succinate, and methylprednisolone by size-exclusion chromatography



Journal of Pharmaceutical and Biomedical Analysis 19(5): 785-792



An analytical HPLC method is reported for simultaneous measurement of low (1.0-100 microg ml(-1)) concentrations of dextran-methylprednisolone succinate (DEX-MPS) and its degradation products methylprednisolone hemisuccinate (MPS) and methylprednisolone (MP). The analytes were detected at 250 nm after resolution using a size exclusion column with a mobile phase of KH2PO4 (10 mM): acetonitrile (3:1) and a flow rate of 1 ml min(-1). The resolution of MP and MPS peaks was substantially affected by the pH of the mobile phase; while MP and MPS co-eluted at pH 3.4, they were baseline-resolved at pH > or = 5. Linear relationships (r > or = 0.997) were found between the detector response and the concentrations of the analytes (1.0-100 microg ml(-1) for MP and MPS and 2.5-100 microg ml(-1) for DEX-MPS). Intra- and inter-run error (< 13%) and precision (CV of < or = 6%) data indicated that the assay could accurately and precisely quantitate all three components in the examined concentration range. The application of the assay to determination of degree of substitution, purity, and stability of DEX-MPS was also demonstrated.

(PDF emailed within 1 workday: $29.90)

Accession: 047373005

Download citation: RISBibTeXText

PMID: 10698542


Related references

Simultaneous analysis of dextran-methylprednisolone succinate, methylprednisolone succinate, and methylprednisolone by size-exclusion chromatography. Journal of Pharmaceutical & Biomedical Analysis 19(5): 785-792, April, 1999

Simultaneous analysis of methylprednisolone, methylprednisolone succinate, and endogenous corticosterone in rat plasma. Journal of Pharmaceutical & Biomedical Analysis 22(6): 1015-1022, July, 2000

Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: Dose-dependent pharmacokinetics in rats. International Journal of Pharmaceutics (Kidlington) 229(1-2): 173-182, 23 October, 2001

Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: Plasma and tissue disposition. Journal of Pharmaceutical Sciences 90(12): 2078-2087, December, 2001

Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: Immunosuppressive effects after in vivo administration to rats. Pharmaceutical Research (New York) 17(11): 1402-1407, November, 2000

Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: immunosuppressive effects after in vivo administration to rats. Pharmaceutical Research 17(11): 1402-1407, 2001

Kinetics of hydrolysis of dextran-methylprednisolone succinate, a macromolecular prodrug of methylprednisolone, in rat blood and liver lysosomes. Journal of Controlled Release 68(1): 53-61, 31 July, 2000

Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: In vitro immunosuppressive effects on rat blood and spleen lymphocytes. International Journal of Pharmaceutics (Kidlington) 207(1-2): 71-76, 10 October, 2000

Comparative pharmacokinetics of methylprednisolone mp and its prodrugs following intravenous doses of methylprednisolone sodium succinate mpss and methylprednisolone suleptanate mpsp in humans. Clinical Pharmacology & Therapeutics 43(2): 189, 1988

Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: Local immunosuppressive effects in liver after systemic administration to rats. Pharmaceutical Research (Dordrecht) 20(2): 198-204, February, 2003

Pilot study of the pharmacokinetics of methylprednisolone after single and multiple intravenous doses of methylprednisolone sodium succinate and methylprednisolone suleptanate to healthy volunteers. Journal of Clinical Pharmacology 34(11): 1109-1115, 1994

Pharmacokinetics of methylprednisolone methylprednisolone sodium succinate and methylprednisolone acetate in dogs. Journal of Pharmaceutical Sciences 75(3): 251-255, 1986

Hplc uv 243 mn method for simultaneous determination of methylprednisolone and methylprednisolone hydrogen succinate in human urine. Journal of Pharmaceutical Sciences 76(11): S15, 1987

Serum and urine methylprednisolone and methylprednisolone sodium succinate assay by a highly sensitive high performance liquid chromatography method. Clinical Chemistry 32(6): 1167, 1986

Pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone in patients undergoing cardiopulmonary bypass. PharmacoTherapy 10(1): 29-34, 1990